HomeSPRINT • STO
add
Sprint Bioscience AB
Previous close
kr 1.76
Day range
kr 1.60 - kr 1.80
Year range
kr 0.76 - kr 2.44
Market cap
124.98M SEK
Avg Volume
96.07K
P/E ratio
8.49
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 16.70M | 40,629.27% |
Operating expense | 15.11M | 35.52% |
Net income | -5.78M | 50.68% |
Net profit margin | -34.64 | 99.88% |
Earnings per share | — | — |
EBITDA | -5.71M | 53.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 36.00M | 132.25% |
Total assets | 48.30M | 109.96% |
Total liabilities | 29.61M | 57.45% |
Total equity | 18.69M | — |
Shares outstanding | 69.82M | — |
Price to book | 6.52 | — |
Return on assets | -30.02% | — |
Return on capital | -69.61% | — |
Cash Flow
Net change in cash
(SEK) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -5.78M | 50.68% |
Cash from operations | -3.66M | 68.88% |
Cash from investing | — | — |
Cash from financing | -225.00K | -1,037.50% |
Net change in cash | -3.89M | 66.90% |
Free cash flow | -1.88M | 75.92% |
About
Founded
2009
Website
Employees
36